SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-18-088407
Filing Date
2018-03-20
Accepted
2018-03-20 07:13:20
Documents
251
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 20-F/A d516109d20fa.htm 20-F/A 27549
  Complete submission text file 0001193125-18-088407.txt   23624768

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT gsk-20171231.xml EX-101.INS 7274280
3 XBRL TAXONOMY EXTENSION SCHEMA gsk-20171231.xsd EX-101.SCH 363353
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gsk-20171231_cal.xml EX-101.CAL 263668
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gsk-20171231_def.xml EX-101.DEF 1133072
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE gsk-20171231_lab.xml EX-101.LAB 1935954
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gsk-20171231_pre.xml EX-101.PRE 1602148
Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GLAXOSMITHKLINE PLC (Filer) CIK: 0001131399 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: 20-F/A | Act: 34 | File No.: 001-15170 | Film No.: 18700645
SIC: 2834 Pharmaceutical Preparations